Brief: iRhythm Technologies Received Regulatory Approval From Japanese Pharmaceutical & Medical Device Agency For Zio 14-Day ECG Monitoring System
11/09/2024 16:13
Sept 11 (Reuters) - iRhythm Technologies Inc IRTC.O :
* IRHYTHM TECHNOLOGIES: RECEIVED REGULATORY APPROVAL FROM
JAPANESE
PHARMACEUTICAL & MEDICAL DEVICE AGENCY FOR ZIO 14-DAY ECG
MONITORING SYSTEM
Source text for Eikon: ID:nGNX4XYMlC
Further company coverage: IRTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on iRhythm Holdings
See all newsiRhythm Holdings, Inc reports results for the quarter ended September 30 - Earnings Summary
iRhythm Q3 revenue slightly misses estimates; net loss widens YoY
Brief: iRhythm Holdings Q3 Revenue USD 221.6 Million Vs. IBES Estimate USD 222.5 Million
Brief: Irhythm Provides Update On Cybersecurity Incident Previously Disclosed In June 2026
Factbox: US companies face rise in cyber attacks